Sörgel F, Kinzig M
Institute for Biomedical and Pharmaceutical Research, Nürnberg-Heroldsberg, Germany.
J Antimicrob Chemother. 1993 Jan;31 Suppl A:39-60. doi: 10.1093/jac/31.suppl_a.39.
The pharmacokinetic properties of piperacillin/tazobactam are summarized. The data on piperacillin show that the behaviour of this well established agent is the same when given in combination with tazobactam as when given alone. Tazobactam shows pharmacokinetic characteristics typical of a beta-lactam compound. It distributes mainly into the extracellular space and shows typical tissue penetration behaviour. The tissue concentrations of piperacillin and tazobactam and their pharmacokinetic profiles in plasma and tissues encourage the view that the synergy observed in vitro will be reflected in clinical use.
总结了哌拉西林/他唑巴坦的药代动力学特性。关于哌拉西林的数据表明,这种成熟药物与他唑巴坦联合使用时的行为与单独使用时相同。他唑巴坦显示出β-内酰胺类化合物典型的药代动力学特征。它主要分布到细胞外间隙,并表现出典型的组织穿透行为。哌拉西林和他唑巴坦在组织中的浓度及其在血浆和组织中的药代动力学特征支持这样一种观点,即体外观察到的协同作用将在临床应用中得到体现。